External validation of the international IgA nephropathy prediction tool in a Thai cohort
Frontiers in Medicine · 18.06.2026 · 13
DOI: 10.3389/fmed.2026.1860001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 18.06.2026. Verfasst von Atthaphong Phongphithakchai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To externally validate the performance of the International IgA Nephropathy Prediction Tool (IIgANPT) in a Thai cohort with biopsy-proven IgA nephropathy and to compare the predictive accuracy of model versions with and without the race variable.
Methods
We conducted a retrospective cohort study to externally validate the IIgANPT in Thai adults with biopsy-proven IgAN at a tertiary-care center. Both model versions (with and without race) were evaluated. The primary outcome was a composite of a sustained 50% decline in estimated glomerular filtration rate (eGFR) or progression to end-stage renal disease (ESKD). Model performance was assessed using discrimination (C-statistic, AUC), calibration (slope and plots), and risk stratification with Kaplan–Meier analysis.
Results
A total of 133 patients were included, with a median follow-up of 3.4 years. During follow-up, 45 patients (33.8%) reached the renal endpoint. The model demonstrated good discrimination, with C-statistics of 0.753 (95% CI 0.68–0.82) and 0.754 (95% CI 0.69–0.82) for models with and without race, respectively. Five-year AUC values were similar (0.790 vs. 0.787). Calibration was broadly preserved, although confidence intervals around calibration slopes were wide. Risk stratification showed clear separation of kidney survival across predefined risk groups (log-rank p < 0.0001).
Conclusion
The IIgANPT demonstrated good discrimination and effective risk stratification in this Thai cohort of patients with biopsy-proven IgAN. Calibration point estimates were close to the ideal range, although precision was limited by wide confidence intervals. Both model versions performed similarly, suggesting that exclusion of the race variable may have limited impact on prognostic performance in this relatively homogeneous population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
- Division of Nephrology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand.
- Department of Regulatory Biochemistry, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Japan.
- Department of Medical Technology, School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
Zitieren
APA
Phongphithakchai, A., Thongrueang, A., Srithongkul, T., Raksasuk, S., Kawakami, F., Tedasen, A., & Chatatikun, M. (2026). External validation of the international IgA nephropathy prediction tool in a Thai cohort. Frontiers in Medicine, 13. https://doi.org/10.3389/fmed.2026.1860001
Vancouver
Phongphithakchai A, Thongrueang A, Srithongkul T, Raksasuk S, Kawakami F, Tedasen A, et al. External validation of the international IgA nephropathy prediction tool in a Thai cohort. Frontiers in Medicine. 2026;13. doi:10.3389/fmed.2026.1860001
BibTeX
@article{Phongphithakchai2026,
author = {Phongphithakchai, Atthaphong and Thongrueang, Attamon and Srithongkul, Thatsaphan and Raksasuk, Sukit and Kawakami, Fumitaka and Tedasen, Aman and Chatatikun, Moragot},
title = {External validation of the international IgA nephropathy prediction tool in a Thai cohort},
journal = {Frontiers in Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fmed.2026.1860001}
}
EUVIMED